Welcure Drugs & Pharmaceuticals share news and announcements

BSE: 524661Pharmaceuticals & BiotechnologySmall Cap

₹0.18₹0.02 (10.00%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹0.20.

52-week range of traded prices to 23 Oct 2026

₹0.17Low, 23 Oct 2026₹0.72High, 23 Oct 2025

Market cap: ₹22 Cr3,646th largest listed
P/E: No recent results
P/B: No recent results
Dividend yield: Nonein the last 12 months
Volume, BSE: 76,25,873

Welcure Drugs & Pharmaceuticals routine notices

125 filed, newest first. Page 1 of 3.

Jun 2026
- 1 Jun · Routine
  Newspaper Clipping of Audited Financials Results for the 4th Quarter and Annual year ended 31st March, 2026. (opens in a new tab)
May 2026
- 30 May · Routine
  Submission of Annual Secretarial Compliance Report for the year ended 31st March. 2026. (opens in a new tab)
Apr 2026
- 23 Apr · Routine
  Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details .... (opens in a new tab)
- 3 Apr · Routine
  Certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018 for the 4th Quarter and Annual year ended 31st MArch, 2026. (opens in a new tab)
Mar 2026
- 26 Mar · Routine
  Intimation of Closure of Trading Window for the 4th Quarter and Annual Year Ended 31 March, 2026 (opens in a new tab)
Feb 2026
- 14 Feb · Routine
  Newspaper Clipping of Unaudited Financials for 3rd Quarter ended December 21, 2025. (opens in a new tab)
Jan 2026
- 5 Jan · Routine
  Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the 3rd Quarter ended 31st December, 2025. (opens in a new tab)
Dec 2025
- 24 Dec · Routine
  Intimation of Closure of Trading Window (opens in a new tab)
Nov 2025
- 15 Nov · Routine
  Newspaper Clipping of Unaudited Financial Results for Quarter and Half Year ended September 30, 2025. (opens in a new tab)
Oct 2025
- 9 Oct · Routine
  Certificate Under Regulation 74(5) of SEBI ( Depository and Participants) Regulation, 2018 for the 2nd Quarter Ended 30th September, 2025. (opens in a new tab)
Sep 2025
- 27 Sep · Routine
  Intimation of Closure of Trading Window (opens in a new tab)
- 4 Sep · Routine
  Newspaper Publication of Notice of AGM of the Company (opens in a new tab)
Aug 2025
- 8 Aug · Routine
  Newspaper clipping of Unaudited Financial Results of Quarter ended June 30, 2025. (opens in a new tab)
Jul 2025
- 21 Jul · Routine
  Certificate Under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2025 (opens in a new tab)
Jun 2025
- 27 Jun · Routine
  Closure of Trading Window for Quarter year ended on 30th June 2025 (opens in a new tab)
May 2025
- 29 May · Routine
  Submission of Annual Secretarial Compliance Report (opens in a new tab)
Apr 2025
- 30 Apr · Routine
  Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details .... (opens in a new tab)
- 10 Apr · Routine
  Certificate under Regulation 74(5) of SEBI(Depository and participants)Regulations,2018 for the Quarter and year ended 31st March 2025. (opens in a new tab)
Mar 2025
- 27 Mar · Routine
  Closure of Trading Window (opens in a new tab)
Feb 2025
- 17 Feb · Routine
  Newspaper Clipping of Unaudited Financial Results of Quarter ended December, 2024 (opens in a new tab)
Jan 2025
- 10 Jan · Routine
  Certificate Under Regulation 74(5) of SEBI(Depository and Participant) Regulation, 2018 for the Quarter Ended 31 December 2024. (opens in a new tab)
Dec 2024
- 27 Dec · Routine
  Intimation of Closure of Trading Window (opens in a new tab)
- 4 Dec · Routine
  Newspaper Clippings of Postal Ballot Notice and Remote E voting Intimation (opens in a new tab)
Nov 2024
- 16 Nov · Routine
  Newspaper Clipping of Unaudited Financials Results of Quarter and Half Year Ended September 30, 2024. (opens in a new tab)
Oct 2024
- 23 Oct · Routine
  Newspaper Advertisement of Notice of Forfeiture of Partly Paid up Equity Shares of the Company (opens in a new tab)
- 8 Oct · Routine
  Certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018 for the quarter and half year ended 30th September, 2024. (opens in a new tab)
Sep 2024
- 26 Sep · Routine
  Intimation of Closure of Trading Window (opens in a new tab)
- 6 Sep · Routine
  Newspaper Advertisement of AGM Notice - Regulation 47 of SEBI (LODR) Regulations, 2015 (opens in a new tab)
Aug 2024
- 16 Aug · Routine
  News paper Publication (opens in a new tab)
Jul 2024
- 12 Jul · Routine
  Certificate under regulation 74(5) of SEBI (DP) Regulations for the quarter ended 30th June, 2024. (opens in a new tab)
Jun 2024
- 27 Jun · Routine
  Trading Window will remain closed from July 01, 2024 till the expiry of 48 hours after declaration of Quarter Ended Unaudited Standalone Financial Results for the Quarter Ended June 30, 2024 (opens in a new tab)
- 13 Jun · Routine
  Submission of Newspaper Advertisement for Extract of Postal Ballot Notice. (opens in a new tab)
- 6 Jun · Routine
  Newspaper Clipping of Audited financial Results of Quarter and Year ended March 31, 2024. (opens in a new tab)
May 2024
- 28 May · Routine
  Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2024 (opens in a new tab)
Apr 2024
- 2 Apr · Routine
  Newspaper publication related to postal ballot (opens in a new tab)
Mar 2024
- 28 Mar · Routine
  Closure of trading window (opens in a new tab)
Feb 2024
- 16 Feb · Routine
  We hereby submit the clippings of Newspapers publication in which Un-Audited Financial Results for the quarter ended 31st December, 2023 have been published. (opens in a new tab)
- 1 Feb · Routine
  WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve With reference .... (opens in a new tab)
Jan 2024
- 6 Jan · Routine
  We are hereby submitting the Certificate under Regulation 74(5) of the SEBI (Depository & Participant) Regulation, 2018 for the quarter ended 31st December, 2023. (opens in a new tab)
Dec 2023
- 29 Dec · Routine
  Trading Window for dealing in the Securities of the Company for all the designated persons (as defined in the said code) has been closed from Monday, 01st January, 2024 till 48 hours after .... (opens in a new tab)
Nov 2023
- 16 Nov · Routine
  With reference to the above mentioned captioned subject, we are hereby submitting the clippings of the English Newspaper "Financial Express" and Hindi newspaper " Jansatta" dated 16th November, .... (opens in a new tab)
- 3 Nov · Routine
  WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 ,inter alia, to consider and approve With reference .... (opens in a new tab)
Oct 2023
- 9 Oct · Routine
  We are hereby submitting the Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter and half year ended 30th September, 2023. (opens in a new tab)
Sep 2023
- 30 Sep · Routine
  With reference to the SEBI (PIT) Regulations, 2015, the "Trading Window" for dealing in securities of the company for all Designated Persons shall be remain closed which shall be effective .... (opens in a new tab)
- 8 Sep · Routine
  We are hereby submitting Intimation of Newspaper Advertisement under Regulation 47 of SEBI (LODR) Regulations, 2015 for Notice of 31st AGM of the Company to be held on Thursday, 28th September, .... (opens in a new tab)
Aug 2023
- 16 Aug · Routine
  In continuation to our letter dated 14th August,2023, regarding approval of Un-Audited Financial Results for Quarter ended 30th June, 2023; Please find enclosed, the newspaper advertisement .... (opens in a new tab)
- 4 Aug · Routine
  WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 ,inter alia, to consider and approve With reference .... (opens in a new tab)
Jul 2023
- 15 Jul · Routine
  We are hereby submitting the certificate under Regulation 74(5) of the SEBI ( Depository & Participant) Regulations, 2018 for the quarter ended 30th June, 2023. (opens in a new tab)
- 13 Jul · Routine
  In continuation with our letter dated 11th July,2023, regarding approval of Audited Financial Results for Quarter and year ended 31st March, 2023; please find enclosed , the newspaper advertisement .... (opens in a new tab)
- 5 Jul · Routine
  WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2023 ,inter alia, to consider and approve With reference .... (opens in a new tab)

Welcure Drugs & Pharmaceuticals routine notices

Jun 2026

May 2026

Apr 2026

Mar 2026

Feb 2026

Jan 2026

Dec 2025

Nov 2025

Oct 2025

Sep 2025

Aug 2025

Jul 2025

Jun 2025

May 2025

Apr 2025

Mar 2025

Feb 2025

Jan 2025

Dec 2024

Nov 2024

Oct 2024

Sep 2024

Aug 2024

Jul 2024

Jun 2024

May 2024

Apr 2024

Mar 2024

Feb 2024

Jan 2024

Dec 2023

Nov 2023

Oct 2023

Sep 2023

Aug 2023

Jul 2023